Devises / GSK
GSK: GSK plc American Depositary Shares (Each representing two Ordin
37.55
USD
0.13
(0.35%)
Le taux de change de GSK a changé de -0.35% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 37.17 et à un maximum de 37.78.
Suivez la dynamique GSK plc American Depositary Shares (Each representing two Ordin. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GSK Nouvelles
- Investing Trump demands pharma CEOs lower drug prices within 60 days
- Zacks Company News for Jul 31, 2025
- Investing U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.06%
- Zacks GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
- Benzinga Why Is GSK Stock Gaining On Wednesday? - GSK (NYSE:GSK)
- Investing FTSE 100 today: Index falls as HSBC, Rio Tinto, BAE results weigh; Bodycote soars
- Zacks GSK (GSK) Q2 Earnings and Revenues Beat Estimates
- Investing GSK in talks with Trump administration on U.S. drug pricing, CEO says
- Investing GSK lifts 2025 forecast after profit jumps on strong HIV, cancer drug sales
- Investing GSK Q2 2025 presentation: Sales up 6%, EPS jumps 15% as Specialty Medicines lead growth
- Investing Morning Bid: No more sleep this week
- Benzinga GSK, Hengrui Pharma Sign Deal For COPD Therapy, 12 Drugs - GSK (NYSE:GSK)
- Investing GSK announces $500 million collaboration with Hengrui Pharma for drug development
- Investing FTSE 100 today: Index slips, pound below $1.35; U.K. retail sales miss in June
- Benzinga GSK's Blood Cancer Drug Review Extended As FDA Seeks More Data - GSK (NYSE:GSK)
- Zacks Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
- Seeking Alpha Dodge & Cox International Stock Fund Q2 2025 Shareholder Letter
- Investing FDA extends review period for GSK’s Blenrep in multiple myeloma
- Seeking Alpha Dodge & Cox Balanced Fund Q2 2025 Shareholder Letter
- Zacks GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth
- Zacks Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
- Investing U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.17%
- Zacks FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
- Zacks These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Range quotidien
37.17
37.78
Range Annuel
31.71
44.27
- Clôture Précédente
- 37.15
- Ouverture
- 37.68
- Bid
- 37.55
- Ask
- 37.85
- Plus Bas
- 37.17
- Plus Haut
- 37.78
- Volume
- 7.175 K
- Changement quotidien
- -0.35%
- Changement Mensuel
- -0.35%
- Changement à 6 Mois
- -1.65%
- Changement Annuel
- -13.97%
03 août, dimanche